Holen Sie sich die Stockscreener-App
4.39
4.15%
-0.19
Apimeds Pharmaceuticals US, Inc. Aktie (APUS) Neueste Nachrichten
MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure - GlobeNewswire Inc.
$Apimeds Pharmaceuticals (APUS.US)$ - Moomoo
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Why Did Apimeds (NYSEAMERICAN:APUS) Skyrocket 42.5 Percent? - kalkine.ca
$Apimeds Pharmaceuticals (APUS.US)$[Worship] - Moomoo
Why Is Apimeds Pharmaceuticals Stock Gaining Monday? - Benzinga
APUS Stock Whipsaws After Huge Run, Drawing Day Traders - Timothy Sykes
APUS Stock Whipsaws As Traders Zero In On Volatility And Cash Burn - StocksToTrade
APUS Stock Whipsaws As Traders Target Extreme Volatility - Timothy Sykes
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
MindWave Innovations Signs Agreement with US-Based - GlobeNewswire
MindWave Innovations Signs Agreement With US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network - Moomoo
Apimeds Pharmaceuticals USErick Frim Resig - Moomoo
Form 8K Apimeds Pharmaceuticals US For: 1 October By Investing.com - Investing.com Nigeria
Apimeds Pharmaceuticals appoints Eric Sherb as chief financial officer - Investing.com
APUS Stock Quote Price and Forecast - CNN
Form 8K Apimeds Pharmaceuticals US For: 29 September By Investing.com - Investing.com Nigeria
Form 8K Apimeds Pharmaceuticals US For: 29 September By Investing.com - Investing.com India
Apimeds Pharmaceuticals US inks two 12-month MindChain service deals for AQUAEChain and FlashChain - TradingView
Environmental credits and match tickets feature in two new deals for Apimeds Pharmaceuticals (APUS). - Stock Titan
Apimeds Pharmaceuticals US (NYSE American: APUS) Subsidiary MindWave Innovations Signs 12-Month Agreement to Build FlashChain - The Globe and Mail
MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media - The Manila Times
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Apimeds Pharmaceuticals US (NYSE American: APUS) Subsidiary MindWave Signs 12-Month Technology Services Agreement with AQUAE Holdings - theglobeandmail.com
APUS Stock Volatility Explodes As Traders Pile Into Momentum - StocksToTrade
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
APUS Stock Volatility Spikes As Traders Target Breakout - timothysykes.com
APUS Stock Whipsaws As Traders Chase Parabolic Pharma Move - StocksToTrade
Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Invest - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Trending Stocks Today | Apimeds Pharmaceuticals Surges 157.64% - moomoo.com
APUS Interactive Stock Chart | Apimeds Pharmaceuticals US, Inc Stock - finance.yahoo.com
Apimeds Pharmaceuticals Stock Skyrockets Thursday: What's Happening? - Benzinga
Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000 - Benzinga
APUS Stock Rockets On Heavy Volume As Traders Hunt Volatility - timothysykes.com
APUS Stock Explodes Higher As Traders Target Volatile Breakout - StocksToTrade
Form 8K Apimeds Pharmaceuticals US For: 23 September By Investing.com - Investing.com Nigeria
IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc. - GlobeNewswire
Apimeds Pharmaceuticals US (APUS) Edges Higher, Testing Key Resistance at $1.74Late Stage Breakouts - careplusvn.com
Sungjoon Chae appointed to Apimeds Pharmaceuticals US board; serves as Co‑CEO - TradingView
Co-CEO joins new 4-person board at Apimeds (APUS) - Stock Titan
Apimeds Pharmaceuticals US Acquires Apitox Royalty and Market Rights From FreeT to Advance U.S. Program - TradingView
Apimeds Pharmaceuticals US to implement 1-for-10 reverse stock split, new CUSIP 03771D201 - TradingView
1.53%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):